Drug Shortage Report for TEVA-ALENDRONATE
Report ID | 103569 |
Drug Identification Number | 02261715 |
Brand name | TEVA-ALENDRONATE |
Common or Proper name | ALENDRONATE 70MG TABS |
Company Name | TEVA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | ALENDRONIC ACID |
Strength(s) | 70MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 4 |
ATC code | M05BA |
ATC description | DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2020-01-15 |
Estimated end date | 2020-02-29 |
Actual end date | 2020-02-06 |
Shortage status | Resolved |
Updated date | 2020-02-07 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2020-01-17 | English | Compare |
v2 | 2020-01-17 | French | Compare |
v3 | 2020-01-24 | English | Compare |
v4 | 2020-01-24 | French | Compare |
v5 | 2020-02-07 | English | Compare |
v6 | 2020-02-07 | French | Compare |
Showing 1 to 6 of 6